ArticleDrug design, development and therapy2024

Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects.

Xuemei He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.